The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMade Tech Regulatory News (MTEC)

Share Price Information for Made Tech (MTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.25
Bid: 16.00
Ask: 16.50
Change: 0.00 (0.00%)
Spread: 0.50 (3.125%)
Open: 16.25
High: 16.50
Low: 16.25
Prev. Close: 16.25
MTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

1 Feb 2024 07:00

RNS Number : 6112B
Made Tech Group PLC
01 February 2024
 

1 February 2024

 

MADE TECH GROUP PLC

("Made Tech" or "the Group")

 

Trading Update and Notice of Results

 

Made Tech, a leading provider of digital, data and technology services to UK public services, is pleased to provide a half year update on trading for the six months ended 30 November 2023 (the "Period"). The Group expects to publish its half-year results for the Period on 26 February 2024.

 

Highlights

 

? Group revenue of c.£19.1m (H1 FY23: £20.6m)

? Adjusted EBITDA1 of c.£1.4m (H1 FY23: £0.5m), representing margin of 7% (H1 FY23: 2% margin)

? Net cash at Period end of £7.9m (H1 FY23: £9.0m; H2 FY23: £8.5m)

? Sales Bookings2 of c.£12.6m (H1 FY23: £32.6m)

? Contracted Backlog3 of c.£61.3m (H1 FY23: £47.8m; H2 FY23: £67.9m)

 

Financials

 

Made Tech is pleased to deliver a strong EBITDA performance in the first half in line with the Board's

expectations. Adjusted EBITDA increased by 180% against the prior period to c.£1.4m. Revenue for the period was c.£19.1m (H1 2023: £20.6m), 7% below that reported in the prior period. 

 

The Adjusted EBITDA margin increase from 2% in H1 2023 to 7% in the Period, was driven by an increase in billable utilisation, a reduction of contractor numbers and targeted restructuring initiatives. Management continues to focus on further productivity and cost control measures to further improve margin performance over time.

 

Made Tech is debt free and has a strong balance sheet with £7.9m net cash at the Period end (H2 2023: £8.5m).

 

During the Period, Made Tech won £12.6m in new contracts (H1 2023: £32.6m) in a challenging procurement market. Included within these wins are three new Sales Bookings collectively worth £10.7m as set out below:

 

Client

Value

Contract duration

Department for Business and Trade

£1.9m

1 years

Government Digital Service

£5.0m

2 years

Ministry of Justice

£3.8m

1.5 years

 

The Board anticipates that the procurement market will be impacted by the uncertainty created by the upcoming General Election in the short term. Notwithstanding this temporary market backdrop the strong improvements made to Made Tech's operating model and margins, the investment in its commercial offering, combined with its strong balance sheet and Contracted Backlog, position the Group well to execute on its growth strategy.

 

Rory MacDonald, CEO of Made Tech, said:

 

"I am pleased to report that we have strengthened the business in the Period, to deliver much improved margins and a credible EBITDA performance.

 

We have a promising pipeline of new business opportunities, although the market is undoubtedly challenging right now and we expect this to remain so ahead of the general election. The medium term drivers of demand in our market remain strong and we are focused on making further improvements to the business and putting all the necessary building blocks in place to enable us to capitalise on the increase in trading momentum that we expect post the election. "

 

Online analyst briefing

 

Made Tech will hold an analyst briefing online at 9.30am Monday, 26 February 2024 in respect of its half-year results. Equity research analysts interested in joining the meeting should contact Belvedere Communications.

 

Notes:

 

All financials are based on unaudited figures.

 

1EBITDA has been adjusted for the exclusion of depreciation, amortisation, exceptional items and share based payment charges

 

2Sales Bookings represent the total value of sales contracts awarded in the Period, to be delivered in FY24-FY27

 

3Contracted Backlog is the value of contracted revenue that has yet to be recognised

 

Market expectations for FY24 as published on Bloomberg: Revenue £40.0m and Adjusted EBITDA £2.0m

 

 Enquiries:

Made Tech Group plc

Rory MacDonald, CEO

Neil Elton, CFO

via Belvedere PR

Singer Capital Markets (Nominated Adviser & Broker)

Jennifer Boorer / Harry Gooden / Asha Chotai 

Tel: +44 20 7496 3000

 

Belvedere Communications (Financial PR)

Cat Valentine

Keeley Clarke

Email: madetech@belvederepr.com 

Tel: +44 7715 769078

Tel: +44 7967 816525

 

About Made Tech:

 

Made Tech is a provider of digital, data and technology services, which enable central government, healthcare, local government organisations and other regulated industries to digitally transform.

 

Made Tech's purpose is to "positively impact the future of society by improving public services technology". To achieve this the company has four key strategic missions: Modernise legacy technology and working practices; Accelerate digital service and technology delivery; Drive better decisions through data and automation; and Enable technology and delivery skills to build better systems.

 

The Group operates from four locations across the UK - London, Manchester, Bristol and Swansea.

 

More information is available at https://investors.madetech.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKFLFXZFLEBBQ
12
Date   Source Headline
1st May 20241:19 pmRNSDirector Share Purchase
23rd Apr 20243:47 pmRNSTR-1
22nd Apr 20247:00 amRNSMade Tech awarded £19.5m new contract with DLUHC
29th Feb 20247:00 amRNSTR-1
26th Feb 20249:09 amRNSHalf Year Results
26th Feb 20247:00 amRNSHalf Year Results
1st Feb 20247:00 amRNSTrading Update and Notice of Results
9th Jan 20247:00 amRNSAppointment of new CFO and Board Changes
17th Nov 20232:48 pmRNSDirector Share Purchase
30th Oct 20237:00 amRNSExercise of options and PDMR Dealing
26th Oct 20231:33 pmRNSResult of AGM
20th Sep 20233:55 pmRNSNotice of AGM and Posting of Annual Report 2023
13th Sep 20237:00 amRNSAudited Final Results 2023
6th Sep 20237:00 amRNSNotice of Results and Online Presentations
16th Aug 20235:26 pmRNSTR-1
25th Jul 20232:43 pmRNSGrant of LTIP Awards
5th Jul 20237:00 amRNSDirector Share Purchase
19th Jun 202310:03 amRNSTR-1
26th May 202312:38 pmRNSHolding(s) in Company
5th May 202312:56 pmRNSTR-1
2nd May 20237:00 amRNSTrading Update
17th Apr 20237:12 amRNSTR1
23rd Feb 20237:05 amRNSLTIP Update and PDMR Dealing
23rd Feb 20237:00 amRNSHalf Year Results
2nd Feb 202311:05 amRNSSecond Price Monitoring Extn
2nd Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20232:05 pmRNSSecond Price Monitoring Extn
1st Feb 20232:00 pmRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSTrading Update and Notice of Results
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
15th Nov 202211:05 amRNSSecond Price Monitoring Extn
15th Nov 202211:00 amRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSNew £10m contract with the Home Office
19th Oct 20225:17 pmRNSResult of AGM, Deferred Shares & Issue of Equity
29th Sep 20227:00 amRNSIssue of New Ordinary Shares to EBT
23rd Sep 20224:31 pmRNSNotice of AGM and Posting of Annual Report 2022
12th Sep 20227:00 amRNSAudited Final Results
26th Aug 20229:00 amRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSNotice of Final Results and Online Presentations
19th Aug 20227:00 amRNSTrading Update
1st Jul 20227:00 amRNSMet Office Contract
24th Jun 20224:41 pmRNSSecond Price Monitoring Extn
24th Jun 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.